Â¥
14.81
Oct 18
New Key Statistics Module, Z-Score and F-Score
SZSE:002275 Key Ratios
Market Cap ¥ M | 8,834.10 |
Enterprise Value ¥ M | 7,730.82 |
P/E(ttm) | 25.53 |
PE Ratio without NRI | 25.06 |
Forward PE Ratio | -- |
Price/Book | 2.97 |
Price/Sales | 4.23 |
Price/Free Cash Flow | 17.57 |
Price/Owner Earnings | 39.59 |
Payout Ratio % | 1.02 |
Revenue (TTM) ¥ M | 2,045.00 |
EPS (TTM) ¥ | 0.58 |
Beneish M-Score | -2.83 |
10-y EBITDA Growth Rate % | 0.80 |
5-y EBITDA Growth Rate % | 2.80 |
y-y EBITDA Growth Rate % | -13.20 |
EV-to-EBIT | 16.91 |
EV-to-EBITDA | 16.91 |
PEG | 8.95 |
Shares Outstanding M | 587.57 |
Net Margin (%) | 16.75 |
Operating Margin % | 21.09 |
Pre-tax Margin (%) | 21.48 |
Quick Ratio | 2.92 |
Current Ratio | 3.31 |
ROA % (ttm) | 8.95 |
ROE % (ttm) | 11.74 |
ROIC % (ttm) | 15.72 |
Dividend Yield % | 4.14 |
Altman Z-Score | 7.78 |
SZSE:002275 Number of Guru Trades
SZSE:002275 Volume of Guru Trades
Gurus Latest Trades with SZSE:002275
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:002275 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Guilin Sanjin Pharmaceutical Co Ltd Insider Transactions
No Available Data